S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.30 (-1.57%)
AAPL   120.07 (-1.63%)
MSFT   227.07 (-0.22%)
FB   258.10 (+1.05%)
GOOGL   2,035.00 (+1.17%)
TSLA   621.99 (-4.78%)
AMZN   2,978.97 (-0.87%)
NVDA   495.08 (-3.34%)
BABA   230.25 (-2.55%)
CGC   31.01 (-6.71%)
GE   13.62 (+1.34%)
MU   84.35 (-5.34%)
NIO   39.30 (-5.37%)
AMD   77.79 (-3.80%)
T   28.93 (+0.73%)
F   11.93 (-1.97%)
ACB   9.81 (-6.21%)
DIS   188.05 (-2.19%)
BA   225.40 (-1.38%)
NFLX   511.28 (-1.81%)
BAC   36.52 (+0.27%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.30 (-1.57%)
AAPL   120.07 (-1.63%)
MSFT   227.07 (-0.22%)
FB   258.10 (+1.05%)
GOOGL   2,035.00 (+1.17%)
TSLA   621.99 (-4.78%)
AMZN   2,978.97 (-0.87%)
NVDA   495.08 (-3.34%)
BABA   230.25 (-2.55%)
CGC   31.01 (-6.71%)
GE   13.62 (+1.34%)
MU   84.35 (-5.34%)
NIO   39.30 (-5.37%)
AMD   77.79 (-3.80%)
T   28.93 (+0.73%)
F   11.93 (-1.97%)
ACB   9.81 (-6.21%)
DIS   188.05 (-2.19%)
BA   225.40 (-1.38%)
NFLX   511.28 (-1.81%)
BAC   36.52 (+0.27%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.30 (-1.57%)
AAPL   120.07 (-1.63%)
MSFT   227.07 (-0.22%)
FB   258.10 (+1.05%)
GOOGL   2,035.00 (+1.17%)
TSLA   621.99 (-4.78%)
AMZN   2,978.97 (-0.87%)
NVDA   495.08 (-3.34%)
BABA   230.25 (-2.55%)
CGC   31.01 (-6.71%)
GE   13.62 (+1.34%)
MU   84.35 (-5.34%)
NIO   39.30 (-5.37%)
AMD   77.79 (-3.80%)
T   28.93 (+0.73%)
F   11.93 (-1.97%)
ACB   9.81 (-6.21%)
DIS   188.05 (-2.19%)
BA   225.40 (-1.38%)
NFLX   511.28 (-1.81%)
BAC   36.52 (+0.27%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.30 (-1.57%)
AAPL   120.07 (-1.63%)
MSFT   227.07 (-0.22%)
FB   258.10 (+1.05%)
GOOGL   2,035.00 (+1.17%)
TSLA   621.99 (-4.78%)
AMZN   2,978.97 (-0.87%)
NVDA   495.08 (-3.34%)
BABA   230.25 (-2.55%)
CGC   31.01 (-6.71%)
GE   13.62 (+1.34%)
MU   84.35 (-5.34%)
NIO   39.30 (-5.37%)
AMD   77.79 (-3.80%)
T   28.93 (+0.73%)
F   11.93 (-1.97%)
ACB   9.81 (-6.21%)
DIS   188.05 (-2.19%)
BA   225.40 (-1.38%)
NFLX   511.28 (-1.81%)
BAC   36.52 (+0.27%)
Log in
NASDAQ:HQY

HealthEquity Competitors

$75.58
-2.60 (-3.33 %)
(As of 03/4/2021 03:59 PM ET)
Add
Compare
Today's Range
$74.75
Now: $75.58
$79.33
50-Day Range
$75.64
MA: $82.47
$91.01
52-Week Range
$34.40
Now: $75.58
$93.32
Volume34,962 shs
Average Volume991,558 shs
Market Capitalization$6.21 billion
P/E Ratio1,511.90
Dividend YieldN/A
Beta1.56

Competitors

HealthEquity (NASDAQ:HQY) Vs. TCOM, FLT, FTCH, LYFT, BR, and AKAM

Should you be buying HQY stock or one of its competitors? Companies in the industry of "business services, not elsewhere classified" are considered alternatives and competitors to HealthEquity, including Trip.com Group (TCOM), FLEETCOR Technologies (FLT), Farfetch (FTCH), Lyft (LYFT), Broadridge Financial Solutions (BR), and Akamai Technologies (AKAM).

Trip.com Group (NASDAQ:TCOM) and HealthEquity (NASDAQ:HQY) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares Trip.com Group and HealthEquity's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trip.com Group$5.13 billion4.51$1.01 billion$1.1633.68
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

Trip.com Group has higher revenue and earnings than HealthEquity. Trip.com Group is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Trip.com Group and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Trip.com Group-9.55%-2.45%-1.25%
HealthEquity0.44%7.65%3.49%

Volatility & Risk

Trip.com Group has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Trip.com Group and HealthEquity, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Trip.com Group051102.69
HealthEquity04812.77

Trip.com Group presently has a consensus price target of $36.5571, indicating a potential downside of 7.22%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Trip.com Group.

Insider and Institutional Ownership

98.0% of HealthEquity shares are held by institutional investors. 23.0% of Trip.com Group shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

HealthEquity beats Trip.com Group on 11 of the 15 factors compared between the two stocks.

FLEETCOR Technologies (NYSE:FLT) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares FLEETCOR Technologies and HealthEquity's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FLEETCOR Technologies$2.65 billion8.76$895.07 million$11.2624.70
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

FLEETCOR Technologies has higher revenue and earnings than HealthEquity. FLEETCOR Technologies is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares FLEETCOR Technologies and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
FLEETCOR Technologies29.55%30.65%8.40%
HealthEquity0.44%7.65%3.49%

Risk and Volatility

FLEETCOR Technologies has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for FLEETCOR Technologies and HealthEquity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
FLEETCOR Technologies041502.79
HealthEquity04812.77

FLEETCOR Technologies presently has a consensus price target of $284.6667, indicating a potential upside of 2.53%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given FLEETCOR Technologies' stronger consensus rating and higher possible upside, equities analysts clearly believe FLEETCOR Technologies is more favorable than HealthEquity.

Insider & Institutional Ownership

94.3% of FLEETCOR Technologies shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 5.7% of FLEETCOR Technologies shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

FLEETCOR Technologies beats HealthEquity on 10 of the 15 factors compared between the two stocks.

Farfetch (NYSE:FTCH) and HealthEquity (NASDAQ:HQY) are both retail/wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Farfetch and HealthEquity's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Farfetch$1.02 billion18.63$-385,300,000.00($1.21)-46.30
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

HealthEquity has lower revenue, but higher earnings than Farfetch. Farfetch is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Farfetch and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Farfetch-77.29%-81.22%-31.98%
HealthEquity0.44%7.65%3.49%

Risk and Volatility

Farfetch has a beta of 3.53, indicating that its stock price is 253% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Farfetch and HealthEquity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Farfetch021102.85
HealthEquity04812.77

Farfetch presently has a consensus price target of $55.0769, indicating a potential downside of 0.13%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Farfetch's stronger consensus rating and higher possible upside, equities analysts clearly believe Farfetch is more favorable than HealthEquity.

Insider & Institutional Ownership

65.7% of Farfetch shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

HealthEquity beats Farfetch on 9 of the 15 factors compared between the two stocks.

Lyft (NASDAQ:LYFT) and HealthEquity (NASDAQ:HQY) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Lyft and HealthEquity's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lyft$3.62 billion5.43$-2,602,240,000.00($9.90)-6.25
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

HealthEquity has lower revenue, but higher earnings than Lyft. Lyft is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Lyft and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Lyft-58.70%-60.70%-27.63%
HealthEquity0.44%7.65%3.49%

Risk and Volatility

Lyft has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Lyft and HealthEquity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Lyft082402.75
HealthEquity04812.77

Lyft presently has a consensus price target of $59.6563, indicating a potential downside of 3.83%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Lyft.

Insider & Institutional Ownership

71.3% of Lyft shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 22.9% of Lyft shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

HealthEquity beats Lyft on 11 of the 15 factors compared between the two stocks.

Broadridge Financial Solutions (NYSE:BR) and HealthEquity (NASDAQ:HQY) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Broadridge Financial Solutions and HealthEquity's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Broadridge Financial Solutions$4.53 billion3.56$462.50 million$5.0327.67
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

Broadridge Financial Solutions has higher revenue and earnings than HealthEquity. Broadridge Financial Solutions is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Broadridge Financial Solutions has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Insider & Institutional Ownership

85.0% of Broadridge Financial Solutions shares are held by institutional investors. Comparatively, 98.0% of HealthEquity shares are held by institutional investors. 2.0% of Broadridge Financial Solutions shares are held by company insiders. Comparatively, 3.7% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Broadridge Financial Solutions and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Broadridge Financial Solutions10.27%48.98%13.16%
HealthEquity0.44%7.65%3.49%

Analyst Ratings

This is a summary of recent recommendations and price targets for Broadridge Financial Solutions and HealthEquity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Broadridge Financial Solutions03302.50
HealthEquity04812.77

Broadridge Financial Solutions presently has a consensus price target of $154.1667, indicating a potential upside of 10.95%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Broadridge Financial Solutions' higher possible upside, equities analysts clearly believe Broadridge Financial Solutions is more favorable than HealthEquity.

Summary

HealthEquity beats Broadridge Financial Solutions on 8 of the 15 factors compared between the two stocks.

Akamai Technologies (NASDAQ:AKAM) and HealthEquity (NASDAQ:HQY) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Earnings & Valuation

This table compares Akamai Technologies and HealthEquity's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akamai Technologies$2.89 billion5.27$478.04 million$3.6125.88
HealthEquity$531.99 million11.67$39.66 million$1.3854.77

Akamai Technologies has higher revenue and earnings than HealthEquity. Akamai Technologies is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Akamai Technologies has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500.

Insider and Institutional Ownership

89.1% of Akamai Technologies shares are owned by institutional investors. Comparatively, 98.0% of HealthEquity shares are owned by institutional investors. 2.4% of Akamai Technologies shares are owned by insiders. Comparatively, 3.7% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Akamai Technologies and HealthEquity's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Akamai Technologies18.01%17.69%9.46%
HealthEquity0.44%7.65%3.49%

Analyst Recommendations

This is a summary of recent ratings and price targets for Akamai Technologies and HealthEquity, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Akamai Technologies071302.65
HealthEquity04812.77

Akamai Technologies currently has a consensus price target of $120.3889, indicating a potential upside of 28.62%. HealthEquity has a consensus price target of $75.2308, indicating a potential downside of 1.45%. Given Akamai Technologies' higher possible upside, research analysts clearly believe Akamai Technologies is more favorable than HealthEquity.

Summary

Akamai Technologies beats HealthEquity on 8 of the 15 factors compared between the two stocks.


HealthEquity Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Trip.com Group logo
TCOM
Trip.com Group
1.0$39.07-1.9%$23.59 billion$5.13 billion-72.35Analyst Report
News Coverage
Gap Down
FLEETCOR Technologies logo
FLT
FLEETCOR Technologies
1.7$278.08-1.5%$23.55 billion$2.65 billion33.54
Farfetch logo
FTCH
Farfetch
1.5$56.02-3.6%$19.71 billion$1.02 billion-16.24Earnings Announcement
Analyst Report
Unusual Options Activity
Gap Up
Lyft logo
LYFT
Lyft
1.5$61.87-0.2%$19.61 billion$3.62 billion-11.52Insider Selling
Broadridge Financial Solutions logo
BR
Broadridge Financial Solutions
2.2$139.18-1.9%$16.43 billion$4.53 billion34.37
Akamai Technologies logo
AKAM
Akamai Technologies
1.9$93.44-0.0%$15.25 billion$2.89 billion27.40Analyst Upgrade
Analyst Revision
Fair Isaac logo
FICO
Fair Isaac
1.8$439.20-3.6%$13.31 billion$1.29 billion55.67Increase in Short Interest
News Coverage
The Western Union logo
WU
The Western Union
2.1$23.49-1.7%$9.81 billion$5.29 billion16.20
WEX logo
WEX
WEX
1.6$209.56-2.8%$9.51 billion$1.72 billion73.27Analyst Report
Insider Selling
Nielsen logo
NLSN
Nielsen
1.1$23.85-1.0%$8.62 billion$6.50 billion-56.78Earnings Announcement
Analyst Report
Analyst Revision
Gap Down
Fiverr International logo
FVRR
Fiverr International
1.2$225.95-7.5%$7.53 billion$107.07 million-525.45Analyst Upgrade
CNXC
Concentrix
1.8$122.77-0.4%$6.35 billion$4.72 billion20.84
CDK Global logo
CDK
CDK Global
2.2$49.51-2.3%$6.17 billion$1.96 billion33.45Increase in Short Interest
Ritchie Bros. Auctioneers logo
RBA
Ritchie Bros. Auctioneers
2.3$51.12-1.9%$5.73 billion$1.32 billion32.35Insider Selling
Grubhub logo
GRUB
Grubhub
1.2$59.24-4.1%$5.72 billion$1.31 billion-47.39
Shift4 Payments logo
FOUR
Shift4 Payments
0.8$77.65-8.6%$5.68 billionN/A0.00Unusual Options Activity
Gap Down
American Well logo
AMWL
American Well
1.3$22.38-3.0%$5.42 billionN/A0.00
TriNet Group logo
TNET
TriNet Group
1.5$76.25-5.4%$5.30 billion$3.86 billion17.57
Maximus logo
MMS
Maximus
2.1$81.84-1.3%$5.09 billion$3.46 billion24.07Analyst Revision
Alliance Data Systems logo
ADS
Alliance Data Systems
2.6$97.30-3.9%$5.02 billion$5.58 billion13.96
MPLN
MultiPlan
1.7$6.41-1.9%$4.36 billionN/A0.00Upcoming Earnings
News Coverage
Envestnet logo
ENV
Envestnet
1.4$69.55-0.6%$3.79 billion$900.13 million-535.00Earnings Announcement
Analyst Report
WNS logo
WNS
WNS
1.8$74.00-1.4%$3.73 billion$928.30 million36.63Analyst Report
Increase in Short Interest
Stamps.com logo
STMP
Stamps.com
1.6$179.08-6.8%$3.51 billion$571.85 million22.19Decrease in Short Interest
HMS logo
HMSY
HMS
1.6$36.74-0.2%$3.26 billion$626.40 million60.23Earnings Announcement
Analyst Revision
ExlService logo
EXLS
ExlService
1.3$86.63-1.0%$2.93 billion$991.35 million38.16Earnings Announcement
Analyst Upgrade
Analyst Revision
News Coverage
Phreesia logo
PHR
Phreesia
1.6$56.94-3.6%$2.61 billion$124.78 million-94.90Decrease in Short Interest
Accolade logo
ACCD
Accolade
1.7$39.06-13.2%$2.45 billionN/A0.00Decrease in Short Interest
Gap Down
NIC logo
EGOV
NIC
1.6$34.31-0.4%$2.32 billion$354.20 million38.12
TechTarget logo
TTGT
TechTarget
1.5$75.84-4.0%$2.22 billion$133.96 million120.38
EVO Payments logo
EVOP
EVO Payments
1.4$25.55-0.7%$2.10 billion$485.78 million-94.63Earnings Announcement
Insider Selling
Repay logo
RPAY
Repay
1.4$23.86-2.2%$1.93 billion$104.60 million-70.17Earnings Announcement
Analyst Report
Unusual Options Activity
Analyst Revision
B. Riley Financial logo
RILY
B. Riley Financial
1.1$62.17-6.2%$1.77 billion$652.11 million39.35Dividend Increase
Cardtronics logo
CATM
Cardtronics
1.3$38.52-0.1%$1.72 billion$1.35 billion77.04
CBIZ logo
CBZ
CBIZ
1.4$31.41-0.7%$1.69 billion$948.42 million22.60Insider Selling
Conduent logo
CNDT
Conduent
1.1$6.15-3.4%$1.35 billion$4.47 billion-1.87
QuinStreet logo
QNST
QuinStreet
1.8$22.78-3.8%$1.26 billion$490.34 million38.61Analyst Downgrade
Radware logo
RDWR
Radware
1.7$25.15-1.4%$1.20 billion$252.07 million86.72
GreenSky logo
GSKY
GreenSky
1.3$6.13-0.5%$1.12 billion$529.65 million122.62Upcoming Earnings
Analyst Upgrade
News Coverage
i3 Verticals logo
IIIV
i3 Verticals
1.9$32.20-4.4%$1.08 billion$150.13 million-805.00
Tabula Rasa HealthCare logo
TRHC
Tabula Rasa HealthCare
1.5$35.04-2.5%$886.58 million$284.71 million-13.17Analyst Downgrade
Unusual Options Activity
Analyst Revision
Viad logo
VVI
Viad
1.9$42.66-1.0%$879.83 million$1.37 billion-4.49News Coverage
Gravity logo
GRVY
Gravity
0.7$120.15-3.6%$865.15 million$307.18 million20.72Decrease in Short Interest
Collectors Universe logo
CLCT
Collectors Universe
0.6$91.92-0.0%$854.76 million$78.89 million63.83News Coverage
OptimizeRx logo
OPRX
OptimizeRx
1.5$45.91-17.2%$812.71 million$24.60 million-120.82Analyst Report
Analyst Revision
Gap Up
IDEX
Ideanomics
0.5$2.85-11.9%$762.32 million$44.57 million-2.42Decrease in Short Interest
Gap Up
Qiwi logo
QIWI
Qiwi
1.9$10.58-3.0%$683.57 million$635.40 million6.92Analyst Upgrade
Rimini Street logo
RMNI
Rimini Street
1.5$10.12-14.0%$663.68 million$281.05 million-38.92Earnings Announcement
Analyst Report
Unusual Options Activity
News Coverage
Gap Down
Cass Information Systems logo
CASS
Cass Information Systems
1.0$44.29-1.1%$644.71 million$157.24 million25.75News Coverage
Priority Technology logo
PRTH
Priority Technology
1.8$7.00-23.6%$581.45 million$371.85 million25.00
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.